Literature DB >> 33336592

Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19.

Zhikun Zeng1, Xiao-Yue Hong1, Yunhui Li2, Wei Chen1, Guangming Ye1, Yirong Li1, Yi Luo1.   

Abstract

Aim: The authors studied the role of soluble ST2 (sST2) in COVID-19 and its relationship with inflammatory status and disease severity. Materials & methods: Serum levels of sST2 and interleukin (IL)-33, C-reactive protein (CRP), serum amyloid protein (SAA), IL-6 and procalcitonin (PCT), and T lymphocyte subsets from 80 subjects diagnosed with COVID-19 including 36 mild, 41 severe and three asymptomatic cases were tested.
Results: Serum sST2 levels were significantly increased in COVID-19 patients, which were positively correlated with CRP, but negatively correlated with CD4+ and CD8+ T lymphocyte counts. Serum sST2 levels in nonsurviving severe cases were persistently high during disease progression.
Conclusion: Serum sST2 level test is helpful for reflecting inflammatory status and illness severity of COVID-19.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; immune response; interleukin-33; soluble ST2

Year:  2020        PMID: 33336592     DOI: 10.2217/bmm-2020-0410

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  14 in total

1.  The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19.

Authors:  Shima Makaremi; Ali Asgarzadeh; Hamed Kianfar; Alireza Mohammadnia; Vahid Asghariazar; Elham Safarzadeh
Journal:  Inflamm Res       Date:  2022-06-25       Impact factor: 6.986

2.  Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19.

Authors:  Georgios Kassianidis; Athanasios Siampanos; Garyphalia Poulakou; George Adamis; Aggeliki Rapti; Haralampos Milionis; George N Dalekos; Vasileios Petrakis; Styliani Sympardi; Symeon Metallidis; Zoi Alexiou; Theologia Gkavogianni; Evangelos J Giamarellos-Bourboulis; Theoharis C Theoharides
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

3.  Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19.

Authors:  Yushan Zhang; Chao Xu; Nelson I Agudelo Higuita; Resham Bhattacharya; Jennifer Holter Chakrabarty; Priyabrata Mukherjee
Journal:  Cell Stress       Date:  2021-12-21

4.  Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19.

Authors:  Torbjorn Omland; Christian Prebensen; Christine Jonassen; My Svensson; Jan Erik Berdal; Ingebjørg Seljeflot; Peder Langeland Myhre
Journal:  Open Heart       Date:  2021-12

Review 5.  CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical Perspectives.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

Review 6.  A Real Pandora's Box in Pandemic Times: A Narrative Review on the Acute Cardiac Injury Due to COVID-19.

Authors:  Amalia-Stefana Timpau; Radu-Stefan Miftode; Daniela Leca; Razvan Timpau; Ionela-Larisa Miftode; Antoniu Octavian Petris; Irina Iuliana Costache; Ovidiu Mitu; Ana Nicolae; Alexandru Oancea; Alexandru Jigoranu; Cristina Gabriela Tuchilus; Egidia-Gabriela Miftode
Journal:  Life (Basel)       Date:  2022-07-20

7.  Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19.

Authors:  Emiko Desvaux; Antoine Hamon; Sandra Hubert; Cheïma Boudjeniba; Bastien Chassagnol; Jack Swindle; Audrey Aussy; Laurence Laigle; Jessica Laplume; Perrine Soret; Pierre Jean-François; Isabelle Dupin-Roger; Mickaël Guedj; Philippe Moingeon
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

8.  Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.

Authors:  Jehan W Alladina; Francesca L Giacona; Emma B White; Kelsey L Brait; Elizabeth A Abe; Sam A Michelhaugh; Kathryn A Hibbert; James L Januzzi; B Taylor Thompson; Josalyn L Cho; Benjamin D Medoff
Journal:  Crit Care Explor       Date:  2021-06-29

Review 9.  Involvement of Il-33 in the Pathogenesis and Prognosis of Major Respiratory Viral Infections: Future Perspectives for Personalized Therapy.

Authors:  Giuseppe Murdaca; Francesca Paladin; Alessandro Tonacci; Matteo Borro; Monica Greco; Alessandra Gerosa; Stefania Isola; Alessandro Allegra; Sebastiano Gangemi
Journal:  Biomedicines       Date:  2022-03-19

Review 10.  Biomarkers Associated with Cardiovascular Disease in COVID-19.

Authors:  Christoph C Kaufmann; Amro Ahmed; Achim Leo Burger; Marie Muthspiel; Bernhard Jäger; Johann Wojta; Kurt Huber
Journal:  Cells       Date:  2022-03-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.